A patent provides its owner with an exclusive right to a new invention. And beginning in the 1990s, the U.S. Patent and Trademark Office granted a multitude to OMRF, sometimes more than a dozen in a single year. Only a decade earlier did Congress give OMRF and others the right to patent inventions that stemmed […]
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
Networking, lab tours highlight first OMRF BioVenture Forum
OMRF’s Charles Esmon was recognized by the AHA as a distinguished scientist.
Trauma is a leading cause of death in people under age 34.